| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.0073 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |